OPPENHEIMER & CO INC – Regeneron Pharmaceuticals, Inc. Transaction History
OPPENHEIMER & CO INC portfolio value:
$8.90M
portfolio value
OPPENHEIMER & CO INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.75% | -365 shares | 1.04M | $688.87 | 12.93K |
| Q2 2022 | share | Decrease | -12.02% | -1.81K shares | -2.69M | $591.13 | 13.29K |
| Q1 2022 | share | Decrease | -11.86% | -2.03K shares | -274K | $698.42 | 15.11K |
| Q4 2021 | share | Decrease | -4.83% | -870 shares | -74K | $642.51 | 17.14K |
| Q3 2021 | share | Increase | +13.97% | 2.20K shares | 2.07M | $605.18 | 18.01K |
| Q2 2021 | share | Increase | +27.44% | 3.40K shares | 2.96M | $558.54 | 15.80K |
| Q1 2021 | share | Increase | +11.58% | 1.28K shares | 498K | $473.14 | 12.40K |
| Q4 2020 | share | Increase | +6.70% | 698 shares | -462K | $483.11 | 11.11K |
| Q3 2020 | share | Increase | +30.85% | 2.45K shares | 866K | $559.78 | 10.41K |
| Q2 2020 | share | Decrease | -21.79% | -2.21K shares | -5K | $623.65 | 7.96K |
| Q1 2020 | share | Increase | +4.51% | 439 shares | 1.31M | $488.29 | 10.18K |
| Q4 2019 | share | Increase | +34.67% | 2.50K shares | 1.65M | $375.48 | 9.74K |
| Q3 2019 | share | Decrease | -9.85% | -790 shares | -505K | $277.4 | 7.23K |
| Q2 2019 | share | Increase | +17.79% | 1.21K shares | -286K | $313 | 8.02K |
| Q1 2019 | share | Decrease | -17.53% | -1.44K shares | -288K | $410.62 | 6.81K |
| Q4 2018 | share | Increase | +1.34% | 109 shares | -208K | $373.5 | 8.25K |
| Q3 2018 | share | Decrease | -1.21% | -100 shares | 447K | $404.04 | 8.15K |
| Q2 2018 | share | Increase | +31.75% | 1.98K shares | 690K | $344.99 | 8.25K |
| Q1 2018 | share | Increase | +4.07% | 245 shares | -106K | $344.36 | 6.26K |
| Q4 2017 | share | Decrease | -22.41% | -1.73K shares | -1.20M | $375.96 | 6.01K |
| Q3 2017 | share | Increase | +10.68% | 748 shares | 26K | $447.12 | 7.75K |
| Q2 2017 | share | Increase | +20.64% | 1.19K shares | 1.19M | $491.14 | 7.00K |
| Q1 2017 | share | Increase | +3.36% | 189 shares | 188K | $387.51 | 5.80K |
| Q4 2016 | share | Decrease | -2.01% | -115 shares | -242K | $367.09 | 5.61K |
| Q3 2016 | share | Decrease | -8.42% | -527 shares | 119K | $402.02 | 5.73K |
| Q2 2016 | share | Increase | +1.23% | 76 shares | -44K | $349.23 | 6.26K |
| Q1 2016 | share | Decrease | -10.54% | -729 shares | -1.52M | $360.44 | 6.18K |